Somatic Advantage 74 Duo

Test Code
SLS162010
Book Now

What is Somatic Advantage 74 (SA74) Duo?

SA74 Duo is a molecular profiling test utilizing both a tissue biopsy and a liquid biopsy.

By analyzing mutations in 74 genes using DNA sequencing and fusions in 14 genes using RNA sequencing, across two sample types, it offers a more comprehensive view of the tumor’s genetic landscape, supporting dynamic and personalized cancer care.

Genes Covered/ No. of Genes: 74 Genes, 14 Fusions

Who Is This Test For?

  • Patients with complex or heterogeneous tumors
  • Individuals undergoing treatment monitoring for tumor evolution, emerging resistance, or recurrence
  • Cases where tissue may be limited, but additional insights can be gained from a liquid biopsy

Key Features

  • Covers mutations in 74 genes using DNA sequencing and fusions in 14 genes using RNA sequencing
  • Uses both tissue and liquid biopsy samples

Clinical Applications

  • Enhances mutation detection sensitivity compared to a single-sample test
  • Supports real-time tracking of resistance mutations and tumor progression
  • Informs adaptive treatment strategies by capturing evolving tumor profiles
  • Valuable in monitoring minimal residual disease (MRD) and assessing treatment response

All Solid Tumors, Comprehensive Profiling

Contact Us